News
5d
MedPage Today on MSNScreening for Depression and Anxiety in Multiple SclerosisTo build a model that used routine clinical information to screen for anxiety and depression, Patten's group studied 828 MS ...
5d
MedPage Today on MSNTolebrutinib Benefits Non-Relapsing Secondary Progressive Multiple SclerosisInvestigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...
Christina Applegate got emotional opening up about her struggle with multiple sclerosis, nearly four years after she was ...
A University of Alberta study shows that rural Albertans living with multiple sclerosis are not as likely as urban patients ...
Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...
Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...
For Pree, diagnosed with multiple sclerosis at 19, finishing college was a challenge. Still, amidst it all, she decided to open up about her journey by sharing her first video on YouTube. Little did ...
British cycling legend Chris Hoy, who has been diagnosed with terminal prostate cancer, told The Times he and his wife Sarra, ...
Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.
Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis (MS) — and a new study ...
A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results